Ind-Swift Laboratories Limited (INDSWFTLAB) Share Price & AI Investment Analysis

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigra. Track Ind-Swift Laboratories Limited's live NSE:INDSWFTLAB share price ₹405.55 (+7.25%), market cap ₹₹35B, P/E 60.3. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for INDSWFTLAB — real-time NSE India stock intelligence.